Background: Methionine synthase reductase gene (MTRR A66G) polymorphism and methionine synthase gene (MTR A2756G) polymorphism have shown an association with idiopathic male infertility risk in several ethnic populations. However, their small sample sizes and inconsistent outcomes have prevented strong conclusions. We performed a meta-analysis with published studies to evaluate the associations of the 2 single nucleotide polymorphisms (SNPs) and idiopathic male infertility risk.
Introduction
Infertility, defined as the failure of a couple to achieve pregnancy after 1 year of unprotected, regular sexual intercourse, affects approximately 15% of all couples attempting to conceive a child. [1] [2] [3] It is known to all that male infertility is a multifactorial and multigenetic disease with a complex pathogenesis that involves lifestyle, environmental risk factors, and individual genetic background. [4, 5] Studies have shown that genetic abnormalities account for approximately 15% of male infertility. [6] Over the years, a large number of studies focusing on the association between male infertility and folate-related enzyme genetic polymorphisms have been carried out.
Folate is essential in DNA synthesis, RNA synthesis, methylation reactions, and protein synthesis, which contribute to the maintenance of genome integrity. [7, 8] Several key enzymes, including methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) are involved in the folate metabolic pathway. [9] MTHFR catalyzes the conversion of 5, 10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the dominant circulating form of folate. Methionine as a precursor for S-adenosylmethionine, is produced via the transfer of a methyl group from 5methyltetrahydrofolate, which is catalyzed by MTR and MTRR. [10, 11] Variations in the genes encoding the mentioned enzymes could be potential risk factors for male infertility. [12] The single-nucleotide polymorphisms (SNPs) in the mentioned enzyme genes, such as MTHFR gene polymorphisms (MTHFR C677T, rs1801133 and MTHFR A1298C, rs1801131), a MS gene polymorphism (MS A2756G, rs1805087, also known as MTR A2756G), and MTRR gene polymorphism (MTRR A66G, rs1801394) have been reported frequently. The MTHFR C677T and A1298C polymorphisms have been investigated in several previous meta-analyses for their role as risk factors for male infertility. However, the role of MTR A2756G and MTRR A66G polymorphisms in the folate metabolic pathway has not yet been fully evaluated for association with the risk of male infertility.
To date, a number of studies have investigated the association between MTR A2756G and MTRR A66G polymorphisms and idiopathic male infertility risk; however, the results remain controversial and previous studies have small patient sample sizes. In 2015, a meta-analysis was performed to explore the association between folate metabolism genes and idiopathic male infertility risk. [13] Six case-control studies involving 1150 cases and 1082 controls were include to assess the association between MTR A2756G polymorphism and idiopathic male infertility risk, and the results showed no association between MTR A2756G polymorphism and idiopathic male infertility risk in both Non-Asian and Asian populations. And no association was observed between MTR A2756G polymorphism and non-obstructive azoospermia (NOA) risk, whereas significant association was only observed in oligoasthenoteratozoospermia (OAT) subgroup in the homozygous genetic model. With regard to the MTRR A66G mutation, 7 case-control studies involving 1369 cases and 1330 controls were included in the meta-analysis. They did not detect any outstanding association between the A66G mutation and idiopathic male infertility risk in the overall analyses for all of the genetic models, and no significant risks were observed among the NOA and OAT types. However, in the subgroup analysis by ethnicity, an increased risk was observed in Asians but not in Europeans in the homozygous genetic model. [13] In 2016, Karimian and Colagar [14] conducted a meta-analysis of 7 case-control studies including 1724 cases and 1678 controls, and their results demonstrated that the MTR A2756G polymorphism is capable of causing idiopathic male infertility susceptibility in both Non-Asian and Asian populations. In 2017, Xu et al [15] conducted a meta-analysis of 7 case-control studies including 1438 cases and 1363 controls, and their results demonstrated that the MTRR A66G polymorphism may be unrelated to idiopathic male infertility in both Non-Asian and Asian populations. And in the stratified analysis by infertility type, the MTRR A66G polymorphism may be associated with OAT risk. Subsequently, a series of novel studies have been performed. In addition, the majority of relevant studies in the Chinese population published in local Chinese journals were not included in these meta-analyses. Therefore, to derive a more precise estimation of these associations, an updated meta-analysis based on 12 studies of MTR A2756G (2454 cases and 2525 controls) and 14 studies of MTR A66G (2620 cases and 2614 controls) was performed.
Materials and methods

Searching strategy
Medline, Embase, Web of Science, CNKI, CBM, VIP, and Wan Fang databases (up to Jun 21, 2019) were searched using the terms: "folate-related enzyme gene," "MTRR or methionine synthase reductase," "MTR, MS, or methionine synthase" "polymorphism, mutation, or variant," "male infertility." In addition, the references of reviews and retrieved articles were also searched to identify other relevant publications. The search was limited to studies published in English or Chinese language. The search strategy flowchart is shown in Fig. 1 . All analyses were based on previous published studies, thus no ethical approval and patient consent are required.
Inclusion criteria and exclusion criteria
The studies included in the present meta-analysis were required to meet the following criteria: studies with full text articles, published in English or Chinese; investigating the association between MTR A2756G or MTRR A66G polymorphism and idiopathic male infertility susceptibility; availability of genotype frequencies or allele frequencies for both cases and controls; casecontrol studies; sufficient genotype data were available for the estimation of odds ratios (ORs) and 95% confidence intervals (CIs). Studies were excluded for the following reasons: non-casecontrol studies; duplicated publications, animal studies, reviews, abstracts, and comments; lack of sufficient data for calculating genotype frequency.
Quality assessment
The quality of the included studies was assessed by the Newcastle-Ottawa Scale (NOS). [16] The NOS contains 8 items for case-control studies. It is categorized into 3 aspects: selection, comparability, and exposure. The methodological quality is judged by a "star" rating system. Selection has a maximum of 4 stars, comparability has a maximum of 2 stars, and exposure has a maximum of 3 stars. Scores ranged from 0 stars (worst) to 9 stars (best). Studies were graded as "high quality" if the score was 7 to 9, "moderate quality" if the score was 4 to 6, and "low quality" if the score was <3. 
Data extraction strategy
The following information was extracted from each study by 2 investigators independently: the first author's name, year of publication, country, genotyping method; sample size of the study case and control groups; results of the Hardy-Weinberg equilibrium test (HWE). Extracted data were entered into a collection form and checked by a third author. Disagreements were resolved by discussion between the 2 investigators (BY and SD).
Statistical analysis
The relationships between MTRR A66G and MTR A2756G gene polymorphism with the idiopathic male infertility risks were analyzed by using 4 models including allele comparison model, dominant model, recessive model, and codominant model. The strength of the association between MTRR A66G and MTR A2756G gene polymorphism with the idiopathic male infertility risks were assessed by the OR with 95% CI. Chi-square-based Q test and the I 2 metric were used to assess heterogeneity between studies. The heterogeneity was considered significant when P < .10 and I 2 > 50%. If the P value for heterogeneity was <.10 and I 2 > 50%, the pooled ORs were analyzed using the randomeffect model. In contrast, we applied the fixed-effect model if P ≥ .10 or I 2 50%. The significance of the pooled OR was determined by the Z-test, and P < .05 was considered as statistically significant. The Reviewer Manager 5.3 (Cochrane Collaboration, http://ims.cochrane.org/revman) and Stata 12.0 (StataCorp LP, College Station, TX, USA) were used for all statistical analyses. Begg test, Egger test, and funnel plots were used to statistically examine any publication bias. Sensitivity analysis was performed to evaluate the stability of the results by sequential removal of each study.
Results
Study characteristics
A total of 376 results were retrieved after first search in Medline, Embase, Web of Science, CNKI, CBM, VIP, and Wan Fang databases. Of these studies, after the first screening, 359 studies were excluded based on inclusion and exclusion criteria. Finally, after our careful selection, 17 case-control studies considering 3269 cases and 3192 controls were included in this meta-analysis. Of these, there were 12 studies of MTRR A2756G with 2454 cases and 2525 controls [8, 9, 14, [17] [18] [19] [20] [21] [22] [23] [24] and 14 studies of MTR A66G with 2620 cases and 2614 controls. [8, 9, [17] [18] [19] [20] [21] [22] [23] [25] [26] [27] [28] [29] In the studies eligible for MTRR A66G, 8 were conducted in Non-Asian populations, and 6 involved Asian populations. For MTR A2756G, 6 studies were conducted in Non-Asian populations, and 6 involved Asian populations. The studies were published between 2006 and 2017. The HWE was performed on all of the included studies, and the genotype distributions in the controls for all studies were consistent with the HWE, except for 3 studies.
The detailed characteristics of all the included studies are shown in Table 1 . And the quality of studies based on the NOS score is presented in Table 2 .
Association of the MTR A2756G polymorphism with idiopathic male infertility
Twelve studies included 4979 individuals, which totally evaluated the influence of MTR A2756G polymorphism on the risk of idiopathic male infertility. Table 3 listed the main results of the meta-analysis of the associations between the A2756G mutation and idiopathic male infertility risk. Figure 2 shows the meta-analysis results for the allele model (G vs A), additive model (GG vs AA), dominant model (GG + AG vs AA), and recessive model (GG vs AG + AA), for which the I 2 value, representing the among-study heterogeneity, was 52%, 0%, 42%, and 0%, respectively. Thus, random-effects models were applied in the allele model. Overall, the results revealed significant association between the MTR A2756G polymorphism and idiopathic male infertility risks (G vs A: OR = 1.18, 95% CI = 1.00-1.40; GG vs AA: OR = 2.03, 95% CI = 1.48-2.77; GG + AG vs AA: OR = 1.16, 95% CI = 1.02-1.32; GG vs AG + AA: OR = 1.97, 95% CI = 1.45-2.68). Sub-group analyses were performed on data stratified by ethnicity, we found that the MTR A2756G polymorphism was associated with a significantly increased idiopathic male infertility risk in Non-Asian population, but not in Asian population. In the stratified analysis by infertility type, we observed a significant association between MTR A2756G polymorphism and NOA risks, and similar results were observed in OAT risks. Furthermore, these data were further stratified by ethnicity, significant risks were observed between MTR A2756G polymorphism and OAT risk in both Non-Asian and Asian populations. However, we found that the Table 1 Characteristics of studies included in meta-analysis.
Genotyping Case Control
Author
Farcas [22] 2009 Romania Non-Asian PCR-RFLP  65  67  40  23  2  27  103  42  24  1  26 108 >0.05 Gava [18] 2011 Brazil Non-Asian TaqMan  133  171  78  23  32  87  179 107  47  17  81 261 <0.05 Karimian [14] 2016 Iran Non-Asian PCR-RFLP  217  223  94  96  27  150 284 133  78  12 102 344 >0.05 Kim [19] 2015 Korea  Asian  PCR-RFLP  85  246  64  20  1  22  148 187  56  3  62 430 >0.05 Kurzawski [23] 2015 Poland Non-Asian TaqMan  284  352  178  93  13  119 449 218 125  9 143 561 >0.05 Lee [8] 2006 Korea  Asian  PCR  360  325  270  79  11  101 619 255  66  4  74 576 >0.05 Li [20] 2015 China  Asian  Sequencing  162  120  124  35  3  41  283 101  17  2  21 219 >0.05 Liu [3] 2012 China  Asian  PCR  75  72  60  14  1  16  134  61  11  0  11 133 >0.05 Murphy [17] 2011 Sweden Non- Asian PCR  147  181  100  41  6  53  241 116  57  8  73 289 >0.05 Ni [21] 2915 China  Asian  SNaPshot  296  204  245  47  4  55  537 163  37  4 45 363 >0.05 Weiner [9] 2014 Russia Non- Asian PCR  273  281  157  98  18  134 412 184  87  10 107 455 >0.05 Wen-Bo [24] 2010 China  Asian  TaqMan  357  283  340  17  0  17  697 261  22  0  22 544 >0.05 MTRR A66G Balkan [26] 2013 Turkey Non-Asian TaqMan  108  125  36  52  20  92  124  35  61  29 119 131 >0.05 Farcas [22] 2009 Romania Non-Asian PCR-RFLP  65  67  13  46  6  58  72  18  42  7  56  78 <0.05 Gava [18] 2011 Brazil Non-Asian TaqMan  133  173  37  62  34  130 136  59  84  30 144 202 >0.05 Kim [19] 2015 [8] 2006 Korea  Asian  PCR  360  325  64  250  46  342 378  72  224  29 282 368 <0.05 Li [20] 2015 China  Asian  PCR  162  120  83  65  14  93  231  70  44  6  56 184 >0.05 Ma [28] 2017 China  Asian  PCR  138  102  66  60  12  84  192  42  48  12  72 132 >0.05 Mfady [25] 2014 Jordan Non- Asian PCR  150  150  48  78  24  126 174  61  67  22 111 189 >0.05 Murphy [17] 2011 Sweden Non- Asian PCR  150  180  50  68  32  132 168  60  88  32 152 208 >0.05 Ni [21] 2915 China  Asian  SNaPshot  296  204  158 119  19  157 435  99  91  14 119 289 >0.05 Ravel [27] 2009 France Non-Asian PCR-RFLP  252  114  27  145  80  292 186  12  60  42  141  81 >0.05 Weiner [9] 2014 Russia Non- Asian PCR  272  324  54  136  82  300 244  57  170  97 364 284 >0.05 Xian-Jun [29] 2007 China  Asian  PCR  165  132  38  72  55  182 148  45  65  22 Quality assessment for all of the included studies.
First author Publishing year Selection Comparability Exposure Total
Balkan [26] 2013 ★★★ ★★ ★★ 7 Farcas [22] 2009 ★★ ★★ ★★ 6 Gava [18] 2011 ★★ ★★ ★★ 6 Karimian [14] 2016 ★★★ ★★ ★★ 7 Kim [19] 2015 ★★★ ★★ ★★ 7 Kurzawski [23] 2015 ★★★ ★★ ★★ 7 Lee [8] 2006 ★★★ ★★ ★★ 7 Li [20] 2015 ★★★ ★★ ★★ 7 Liu [3] 2012 ★★★ ★★ ★★ 7 Fang-Fang and Hou-Zhao [28] 2017 ★★ ★ ★★ 5 Mfady [25] 2013 ★★★ ★★ ★★ 7 Murphy [17] 2011 ★★★ ★★ ★★ 7 Ni [21] 2915 ★★★ NA ★★ 5 Ravel [27] 2009 ★★ ★★ ★★ 6 Weiner [9] 2014 ★★★★ ★★ ★★ 8 Xian-Jun and Chao-Jun [29] 2007 ★★★ ★★ ★★ 7 Wen-Bo et al [24] 2010 ★★★ ★★ ★★ 7 Table 3 Meta-analysis of the association of MTR A2756G polymorphism with idiopathic male infertility. MTR A2756G polymorphism was associated with a significantly increased NOA risk in Non-Asian population, but not in Asian population.
Infertility
Association of the MTRR A66G polymorphism with idiopathic male infertility
Fourteen studies included 5234 individuals, which totally evaluated the influence of MTRR A66G polymorphism on the risk of idiopathic male infertility. The main results of the metaanalysis on the association between the MTRR A66G polymorphism and risk of idiopathic male infertility were listed in detail in Table 4 . Figure 3 shows the overall meta-analysis results for the allele model (G vs A), additive model (GG vs AA), dominant model (GG + AG vs AA), and recessive model (GG vs AG + AA), for which the I 2 value, representing the among-study heterogeneity, was 47%, 36%, 31%, and 26%, respectively. Thus, random-effects models were applied in the allele model. Overall, the results revealed no significant association between MTRR A66G polymorphism and idiopathic male infertility risks (G vs A: OR = 1.06, 95% CI = 0.95-1.19; GG vs AA: OR = 1.20, 95% CI = 0.95-1.51; GG + AG vs AA: OR = 1.05, 95% CI = 0.93-1.19; GG vs AG + AA: OR = 1.13, 95% CI = 0.98-1.31). Subgroup analyses were performed by ethnicity, we observed a significant association between MTRR A66G polymorphism and idiopathic male infertility risks in Asian population in recessive model (GG vs AG + AA: OR = 1.44, 95% CI = 1.09-1.90), whereas there was no significantly elevated infertility risks associated with the MTRR A66G polymorphism and idiopathic male infertility in Non-Asian population in any of the genetic models. Furthermore, in the stratified analysis by infertility type, we observed a significant association between MTRR A66G polymorphism and OAT risks, however, no statistically significant increased risk of NOA was found in any of the genetic models. Furthermore, these data were further stratified by ethnicity, no significant risks were observed between MTRR A66G polymorphism and NOA risk both in Non-Asian and Asian populations. However, significant association was observed between MTRR A66G polymorphism and OAT risk in Asian population, but not in Non-Asian population.
Sensitivity analyses and publication bias
No evidence of obvious asymmetry was observed in the funnel plots in any of the models on the 2 SNPs ( Figs. 4 and 5 ). In addition, Begg tests and Egger tests were used to calculate the potential publication bias, and no indication of publication bias was identified in the studies on the 2 SNPs ( Table 5 ). The sensitivity analyses were performed to investigate the pooled ORs through excluding one study each time, and the results showed no individual study had substantial influence on the overall pooled ORs in all genetic models ( Figs. 6 and 7) . That is to say, the results of this meta-analysis are relatively stable.
Discussion
The folate metabolism pathway plays an important role in DNA methylation, DNA repair, and DNA synthesis. [14, 30, 31] Abnormal folate metabolism has been proposed as a factor in male infertility. MTR and MTRR are the key enzymes implicated in the folate metabolic pathways and are crucial for DNA methylation and spermatogenesis. [9, 32] MTR is critical for homocysteine metabolism, and MTRR is required to maintain MTR in its active state. [33] The SNPs of these folate-related enzymes gene can impair folate absorption or disturb the balance between folate derivatives by impacting the activity, stability, or level of the corresponding enzymes. [34] The mechanisms of pathogenesis may involve changes of enzyme structure and mRNA properties that are due to these folate-related enzymes gene polymorphisms. [35] There is increasing evidence investigating the association between MTR A2756G and MTRR A66G polymorphisms and risk of idiopathic male infertility. Gava et al [18] reported that the combinatory analysis of the MTRR A66G polymorphism did not show difference between cases and controls, and the MTR A2756G polymorphism could be an important genetic factor predisposing to idiopathic infertility in Brazilian men. Li et al [20] revealed an association between the SNP A66G in the MTRR gene and idiopathic male infertility, no significant association was found between SNP A2756G in the MS gene and idiopathic male infertility risk in Chinese population. However, Farcas et al [22] found there is no significant association of SNP A2756G in the MS gene or SNP A66G in the MTRR gene with idiopathic male infertility risk in Romanian population group. Similarly, Kurzawski et al [23] found that the MTR A2756G and MTRR A66G polymorphism are not major risk factors for nonobstructive idiopathic male infertility in the Polish population. This difference among studies may be due to small sample sizes, study differences in genotyping method or population substructure, or other factors. Despite the fact that several meta-analyses have been performed to evaluate the association between MTR A2756G, MTRR A66G polymorphisms and risk of idiopathic male infertility, to the best of our knowledge, this is the most updated meta-analysis which included 12 studies of MTRR A2756G with 4979 individuals and 14 studies of MTR A66G with 5234 individuals. In the present study, significant association was observed between MTR A2756G polymorphism and idiopathic male infertility in the overall population. In a subgroup analysis by nationality, we have found a significant association between the MTR A2756G polymorphism and idiopathic male infertility in Non-Asians, but not in Asian population, which was consistent with a previous meta-analysis based on Chinese population. [36] Similarly, the MTR A2756G polymorphism was significantly associated with NOA and OAT in Non-Asian, but not in Asian population in any of the genetic models. In a more recent meta-analysis by Karimian and Colagar, [14] they have suggested that MTR A2756G polymorphism was associated with idiopathic male infertility in both Non-Asian and Asian populations. In addition, they have found that MTR A2756G polymorphism significantly associated with NOA and OAT risk in the overall population. As regard to the MTRR A66G polymorphism, no significant association was found with idiopathic male infertility in the overall population, however, we have observed that the MTRR A66G polymorphism associated with OAT in Asians but not Non-Asians. A previous meta-analysis conducted by Xu et al [10] have suggested MTRR A66G polymorphism was not associated with idiopathic male infertility in both Non-Asian and Asian populations, however, in a subgroup analysis by infertility type, significant association was found between MTRR A66G polymorphism and OAT. A more recent meta-analysis conducted by Shi et al [37] have suggested MTRR A66G polymorphism was significantly associated with idiopathic male infertility in Asian populations. The present study, however, has several advantages compared with the previous meta-analyses. First, more recently-published studies were included in the present meta-analysis, which may underscore the reliability of our findings. Second, Chinese database were searched to more comprehensively assess studies in Chinese populations. Third, the present study added additional subgroup analyses by ethnicity to evaluate the relationship of the 2 SNPs with NOA and OAT. These advantages allowed us to more precisely assess the MTR A2756G, MTRR A66G polymorphisms and idiopathic male infertility risk associations than previous meta-analyses. Some limitations of the present study should be considered when interpreting the results. First, for subgroup analysis, the number of included studies was relatively small, therefore, limited data were available. Second, we did not estimate the potential gene-gene and gene-environment interactions due to the lack of information available in the original studies. Third, other clinical data, such as sources of control, subject age, and semen quality, were not considered here due to a lack of information. Finally, our meta-analysis was based on published articles, and there was no sufficient data for adjustment for individual level factors including diet, obesity, and smoking, which might affect the genetic effect.
Conclusion
In summary, this meta-analysis provides evidence that the MTR A2756G polymorphism may contribute to genetic susceptibility to the risk of idiopathic male infertility in Non-Asian, but not to Asian population. The MTRR A66G polymorphism is associated with risk for OAT in Asian, but not in Non-Asian population. Nevertheless, more large sample and representative populationbased cases and well-matched controls are needed to validate our results.
